FreeIn Brief Carlos Arteaga awarded $600,000 to study breast cancer therapy resistance September 28, 2018Vol.44 No.36
FreeIn Brief ASCO recognizes Rep. Kevin Yoder with 2018 Congressional Leadership Award September 28, 2018Vol.44 No.36
FreeIn Brief Cuomo announces U.S.-Cuba venture to develop new cancer treatments September 28, 2018Vol.44 No.36
Free In Baselga’s wake: Debate focuses on COIs of academics on boards of for-profit firms September 28, 2018Vol.44 No.36By Paul Goldberg
Free Oregon flirts with—and quickly abandons—plan to deny Medicaid payment for next-generation sequencing September 28, 2018Vol.44 No.36By Matthew Bin Han Ong
Conversation with The Cancer LetterFree WVU’s Goldberg: Oregon draft guidance would widen disparities for low-income cancer patients September 26, 2018Vol.44 No.36By Matthew Bin Han Ong
Conversation with The Cancer LetterFree UIC’s Stewart: Oregon draft guidance is “an assault on the treatment of underrepresented populations” September 26, 2018Vol.44 No.36By Matthew Bin Han Ong
Free Oregon weighs plan to deny Medicaid payment for NGS as panel declares “no evidence of clinical utility” September 26, 2018By Matthew Bin Han Ong
FreeTrials & Tribulations Shrinking oncology phase I clinical trials: If the drug is a breakthrough, why would you ever want to utilize the maximally tolerated dose? September 21, 2018Vol.44 No.35By Mark J. Ratain
